Premium CPG · 02 · Answer

Should a premium consumer brand sell to a strategic acquirer or stay independent?

Whatever you decide, decide it knowing you cannot price it. Across the whole 2024–2026 window, exactly two acquirers in premium consumer disclosed a multiple. PepsiCo paid $1.95 billion for poppi and $1.2 billion for Siete Foods and published revenue for neither. The prices are knowable. The multiples are not.

The evidence

The only two disclosed multiples in the window.

Celsius on Alani Nu, stated in the release: “approximately 12x fully synergized 2024A EBITDA of $137 million.” Keurig Dr Pepper on GHOST: “an approximate 3x net revenue multiple on a projected 2024 basis.” That is the entire disclosed field.

What the rest look like.

PepsiCo / poppi: $1.95bn including $300m of tax benefits, net $1.65bn, no revenue disclosed. PepsiCo / Siete Foods: $1.2bn, with “additional terms of the acquisition were not disclosed.” Unilever / Dr. Squatch: no terms at all. Duckhorn, Kellanova and WK Kellogg: not computable from the filings reached.

One computes, because the target was already public.

e.l.f. Beauty bought rhode for $1bn — $800m at close and $200m earnout — against $212m of net sales in the twelve months to March 31, 2025. That is 3.77x at close and 4.72x with the earnout, and it computes only because rhode's number was in the deal materials.

Staying independent is documented too, and it is not free.

Beyond Meat's Q3 2025: net revenues $70.2m against $81.0m; nine-month $213.9m against $249.8m; cash $117.3m, down from $131.9m; nine-month operating cash flow −$98.1m. The October 2025 notes exchange cancelled $1,114,603,000 of 2027 principal for $208.7m of 2030 notes and 316,150,176 new shares.

And a valuation you will hear quoted should carry a flag.

Olipop raised $50m at a $1.85bn valuation in February 2025 on “over $400m in revenue for fiscal year 2024” — company-supplied, with the revenue definition unstated. The implied multiple is omitted here deliberately: a multiple on an unaudited denominator is not a comparable.

What would have to be true for this to be wrong

If a strategic has already made an offer, the comparables question collapses — you are not pricing a market, you are pricing one counterparty against your own plan, and your plan is a number you actually have. The evidence above bites when a founder is deciding whether to open a process at all, on the strength of what other people are reported to have got.

Sources: SEC EDGAR full-text search and company filings, with each figure's period stated above. AI-answer measurements are CULT+MATH primary research, criteria registered before retrieval. Published 2026-10-21 by Ipalibo Da-Wariboko, CULT+MATH LLC. Figures carry the date they were pulled; where a number could not be sourced, this page says so and gives none.

This is one of six decisions covered in the premium CPG decision brief — each with the evidence behind it, who owns it, who it is contested with, and what would have to be true for the answer to flip.

See the brief →